Evidence map›Paper›PMID 39670291›Full record

ArticleInternational journal of urology : official journal of the Japanese Urological Association2025

Prostate cancer burden in South Asia: A systematic analysis of global burden of disease data (1990-2021).

Vijay Kumar, Diptismita Jena, Quazi Syed Zahiruddin, R Roopashree, Mandeep Kaur, Manish Srivastava, Amit Barwal, G V Siva Prasad, Pranchal Rajput, Rukshar Syed and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of urology : official journal of the Japanese Urological Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Vijay KumarGlobal Center for Evidence Synthesis, Chandigarh, India.ORCID https://orcid.org/0009-0003-0173-1091
Diptismita JenaCenter for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
Quazi Syed ZahiruddinSouth Asia Infant Feeding Research Network (SAIFRN), Division of Evidence Synthesis, Global Consortium of Public Health and Research, Datta Meghe Institute of Higher Education, Wardha, India.
R RoopashreeDepartment of Chemistry and Biochemistry, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
Mandeep KaurDepartment of Allied Healthcare and Sciences, Vivekananda Global University, Jaipur, Rajasthan, India.
Manish SrivastavaDepartment of Endocrinology, NIMS University, Jaipur, India.
Amit BarwalChandigarh Pharmacy College, Chandigarh Group of College, Jhanjeri, Mohali, Punjab, India.
G V Siva PrasadDepartment of Chemistry, Raghu Engineering College, Visakhapatnam, Andhra Pradesh, India.
Pranchal RajputSchool of Applied and Life Sciences, Division of Research and Innovation, Uttaranchal University, Dehradun, India.
Rukshar SyedIES Institute of Pharmacy, IES University, Bhopal, Madhya Pradesh, India.
Gajendra SharmaNew Delhi Institute of Management, Tughlakabad Institutional Area, New Delhi, India.
Sunil KumarDepartment of Microbiology, Graphic Era (Deemed to be University), Clement Town Dehradun, India.
Nagavalli ChilakamNoida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, India.
Ganesh BushiSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India.
Hassan Basri Jahubar SathikUniversity of Cyberjaya, Persiaran Bestari, Cyber 11, Cyberjaya, Selangor, Malaysia.
Rachana MehtaClinical Microbiology, RDC, Manav Rachna International Institute of Research and Studies, Faridabad, Haryana, India.
Sanjit SahDepartment of Paediatrics, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India.ORCID https://orcid.org/0009-0008-5017-083X
Muhammed ShabilUniversity Center for Research and Development, Chandigarh University, Mohali, Punjab, India.
Abhay M GaidhaneJawaharlal Nehru Medical College, and Global Health Academy, School of Epidemiology and Public Health, Datta Meghe Institute of Higher Education, Wardha, India.
Hashem Abu SerhanDepartment of Ophthalmology, Hamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0002-2953-2188

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe objectives of this study were to analyze trends in prostate cancer incidence, incidence, mortality, and disability-adjusted life years (DALYs) from 1990 to 2021 via data from the Global Burden of Disease (GBD) study in South Asia. Additionally, the study projects future prostate cancer incidence rates up to 2031 to inform public health interventions in South Asia.

methodsData covering South Asian countries such as Bangladesh, Bhutan, India, Nepal, and Pakistan were obtained from the GBD 2021 portal. Age-standardized rates (ASRs) for prostate cancer metrics, including incidence (ASIR), prevalence (ASPR), mortality (ASMR), and DALYs (ASDR), were analyzed via joinpoint and ARIMA modeling techniques. Geographic variations in ASRs were mapped via QGIS software.

resultsThe prostate cancer ASIR, ASPR, and ASDR significantly increased from 1990 to 2021, particularly among individuals aged 60-65 years. The highest incidence and mortality rates were observed in Pakistan. The total percentage change in incidence in India was the highest at 61%. Projections indicate a continued rise in prostate cancer incidence, with South Asia's ASIR expected to reach 9.34 per 100 000 by 2031.

conclusionsThe growing burden of prostate cancer in South Asia highlights the need for enhanced screening programs, public awareness, and healthcare infrastructure improvements. Without intervention, the increasing incidence and mortality rates could strain healthcare resources, emphasizing the urgency of region-specific public health strategies.

Indexed as

Global Burden of DiseaseProstatic NeoplasmsAdultAgedAsia, SouthernDisability-Adjusted Life YearsHumansIncidenceMaleMiddle AgedPrevalenceAsian populationsGenital neoplasmsGlobal burden of diseaseProstatic neoplasms

Identifiers

PMID39670291
PMCPMC11923514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.